Notice NOT-AG-24-090 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-25-091 from the NIH Guide for Grants and Contracts. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) announces a program that provides NIDDK-supported K01, K08, K23, and K25 recipients the opportunity to apply for Small Grant (R03) support at some point during the latter years of their award period of their K award. Through the use of this mechanism, the NIDDK is seeking to enhance the capability of its K01, K08, K23, and K25 award recipients to conduct research as they complete their transition to fully independent investigator status. The R03 grant mechanism supports different types of projects, including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology. The R03 is, therefore, intended to support research projects that can be carried out in a short period of time with limited resources and that may provide preliminary data to support a subsequent R01, or equivalent, application.

Notice NOT-AG-24-091 from the NIH Guide for Grants and Contracts

Notice NOT-AI-25-019 from the NIH Guide for Grants and Contracts

Notice NOT-CA-25-031 from the NIH Guide for Grants and Contracts

Notice NOT-AG-24-033 from the NIH Guide for Grants and Contracts

Notice NOT-OD-25-061 from the NIH Guide for Grants and Contracts

Notice NOT-OD-25-054 from the NIH Guide for Grants and Contracts

Notice NOT-OD-25-062 from the NIH Guide for Grants and Contracts

Notice NOT-OD-25-060 from the NIH Guide for Grants and Contracts

Notice NOT-CA-25-028 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-25-090 from the NIH Guide for Grants and Contracts. NIDDK supports investigator-initiated, high-risk multi-center (more than one center) clinical studies through a two-part process that may include an implementation planning cooperative agreement (U34). The U34 is designed to: 1) Permit early peer review of the rationale for the proposed clinical study; 2) Permit assessment of the design and protocol of the proposed study; 3) Provide support for the development of documents needed for the conduct of the study, including a manual of operations; and 4) Support the development of other essential elements required for the conduct of the clinical study. The proposed clinical study should be hypothesis-driven and focus on a disease in the mission of NIDDK. Consultation with NIDDK scientific staff is strongly encouraged prior to the submission of the U34 application.

Funding Opportunity PAR-25-312 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) establishes an accelerated review/award process to support time-sensitive research to evaluate a new policy or program that is likely to influence obesity related behaviors (e.g., dietary intake, physical activity, or sedentary behavior) and/or weight outcomes in an effort to prevent or reduce obesity. This NOFO is intended to support research where opportunities for empirical study are, by their very nature, only available through expedited review and funding. All applications to this NOFO must demonstrate that the evaluation of an obesity related policy and /or program offers an uncommon and scientifically compelling research opportunity that will only be available if the research is initiated with minimum delay. For these reasons, applications in response to this time-sensitive NOFO are not eligible for re-submission. It is intended that eligible applications selected for funding will be awarded within 4 months of the application due date. However, administrative requirements and other unforeseen circumstances may delay issuance dates beyond that timeline.

Funding Opportunity RFA-HS-25-001 from the NIH Guide for Grants and Contracts. The purpose of this is NOFO is to disseminate patient-centered outcomes (PCOR) evidence for Long COVID care into clinical practice through clinical decision support (CDS) that is consistently updated as best practices and new evidence emerge.

Competitive: Hull University Teaching Hospitals NHS Trust: Detailed job description and main responsibilities For further details with regard to this vacancy opportunity, please see the attached Job Descript Cottingham, United Kingdom

GBP 48,235.00 - 57,255.00 per year: University of Oxford: The Kennedy Institute at the University of Oxford has an exciting opening for an experienced bioinformatician to join the group of Associate Professor Oxford, United Kingdom

Competitive: Kemio Consulting: 08th January, 2025 Senior Bioinformatician Cambridge - 3 days onsite Are you experienced working with Microbial genomic data? Are you able to ide Cambridgeshire, United Kingdom

GBP 38,232.00 - 39,866.00 per year: King's College London: About Us The post will be based in the Department of Medical and Molecular Genetics and the St John's Institute of Dermatology at King's College Lon London, United Kingdom

GBP 38,674.00 - 46,913.00 per year: University of Oxford: We have an opportunity for a Bioinformatician to work closely with the Centre for Genomic Pathogen Surveillance team of software engineers and data an Oxford, United Kingdom

Funding Opportunity PAR-25-068 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications for innovative basic and translational pilot research projects within the mission of the NIDDK that are aligned with NIH HIV/AIDS research priorities. These priorities were most recently outlined by the NIH Office of AIDS Research (OAR) in NOT-20-018, UPDATE: NIH HIV/AIDS Research Priorities and Guidelines for Determining HIV/AIDS Funding, scientific priorities. Potential topics could address multiple overarching priorities. These include elucidation of unique pathophysiological mechanisms contributing to HIV comorbidities, coinfections, and complications (CCCs) affecting organs, tissues, and processes within the mission of the NIDDK. Likewise, interrogations into biological mechanisms underlying HIV reservoirs in NIDDK-relevant tissues are important for developing strategies for long-term viral suppression or eradication. Finally, health-impeding social determinants of health may affect CCCs or viral reservoirs within NIDDK's mission through multiple pathways.